OldTrapper
Council Member
It is not because of Obama, or the ACA:
https://www.usatoday.com/story/news/health/2019/05/13/teva-and-other-generic-drug-makers-accused-price-fixing/1190531001/
A coalition of attorneys general from 43 states and Puerto Rico claim in a federal lawsuit that generic drug manufacturers conspired to fix prices and markets of 114 drugs for both minor infections and chronic diseases such as arthritis, cancer, diabetes and HIV.
The sweeping 510-page lawsuit filed Friday at U.S. District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a "fair share" of the generic drug market and avoid price-lowering competition.
The lawsuit also names 15 pharma executives in a price-fixing conspiracy that allegedly overcharged states and consumers billions of dollars.
Congress has sought to lower drug prices through policies that encourage robust competition among generic drug manufacturers.
But Connecticut Attorney General William Tong said investigators have obtained emails. text messages, phone record and accounts from former company insiders that show a years-long effort by generic drugmakers to "fix prices and divide market share."
https://www.usatoday.com/story/news/health/2019/05/13/teva-and-other-generic-drug-makers-accused-price-fixing/1190531001/
A coalition of attorneys general from 43 states and Puerto Rico claim in a federal lawsuit that generic drug manufacturers conspired to fix prices and markets of 114 drugs for both minor infections and chronic diseases such as arthritis, cancer, diabetes and HIV.
The sweeping 510-page lawsuit filed Friday at U.S. District Court in Connecticut alleges Teva, Pfizer, Mylan, and 17 other pharmaceutical companies worked in tandem to create a "fair share" of the generic drug market and avoid price-lowering competition.
The lawsuit also names 15 pharma executives in a price-fixing conspiracy that allegedly overcharged states and consumers billions of dollars.
Congress has sought to lower drug prices through policies that encourage robust competition among generic drug manufacturers.
But Connecticut Attorney General William Tong said investigators have obtained emails. text messages, phone record and accounts from former company insiders that show a years-long effort by generic drugmakers to "fix prices and divide market share."